Validation of Quality Control of 68Ga-DOTA-TATE

被引：0
|
作者：
Chan, J. G. [1 ]
Young, K. [1 ]
Iftikhar, F. [1 ]
Sachinidis, J. I. [1 ]
Ackermann, U. [1 ]
Scott, A. M. [1 ]
机构：
[1] Austin Hlth, Heidelberg, Vic, Australia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P282
引用
收藏
页码：S438 / S438
页数：1
相关论文
共 50 条
  • [41] Ectopic ACTH and CRH Co-secreting Tumor Localized by 68Ga-DOTA-TATE PET/CT
    Papadakis, Georgios Z.
    Bagci, Ulas
    Sadowski, Samira M.
    Patronas, Nicholas J.
    Stratakis, Constantine A.
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (07) : 576 - 578
  • [42] Comparison of positron emission tomography with 68Ga-DOTA-TATE and 18F FDG in neuroendocrine tumours
    Yilmaz, S.
    Demirci, E.
    Ocak, M.
    Gunes, B.
    Kabasakal, L.
    Halac, M.
    Araman, A.
    Decristoforo, C.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S382 - S382
  • [43] The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma: preliminary results
    Sonmezoglu, Kerim
    Vatankulu, Betul
    Elverdi, Tugrul
    Akyel, Resit
    Erkan, Melih E.
    Halac, Metin
    Ocak, Meltem
    Demirci, Emre
    Aydin, Yildiz
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (01) : 76 - 83
  • [44] Head-to-Head Comparison of 68Ga-FAPI-04 and 68Ga-DOTA-TATE PET/CT in Recurrent Medullary Thyroid Cancer
    Isik, Emine Goknur
    Simsek, Duygu Has
    Gul, Nurdan
    Erturk, Sukru Mehmet
    Buyukkaya, Fikret
    Selcukbiricik, Ozlem Soyluk
    Iscan, Ahmet Yalin
    Ozkan, Zeynep Gozde
    Sanli, Yasemin
    Mudun, Ayse
    Kuyumcu, Serkan
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (02) : e80 - e86
  • [45] Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
    Cheng, Monica
    Tann, Mark
    HEPATOBILIARY SURGERY AND NUTRITION, 2022,
  • [46] Head-to-Head Comparison of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in Patients With Tumor-Induced Osteomalacia: A Prospective Study
    Hou, Guozhu
    Zhang, Yuwei
    Liu, Yu
    Wang, Peipei
    Xia, Weibo
    Xing, Xiaoping
    Huo, Li
    Li, Fang
    Jing, Hongli
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Identification, characterization and suppression of side-products formed during the synthesis of high dose 68Ga-DOTA-TATE
    Mu, Linjing
    Hesselmann, Rolf
    Oezdemir, Ufuk
    Bertschi, Louis
    Blanc, Alain
    Dragic, Martina
    Loefflerd, Dirk
    Smuda, Christoph
    Johayem, Anass
    Schibli, Roger
    APPLIED RADIATION AND ISOTOPES, 2013, 76 : 63 - 69
  • [48] PET/CT With 68Ga-DOTA-TATE for Diagnosis of Neuroendocrine Differentiation in Patients With Castrate-Resistant Prostate Cancer
    Gofrit, Ofer Nathan
    Frank, Stephen
    Meirovitz, Amichay
    Nechushtan, Hovav
    Orevi, Marina
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (01) : 1 - 6
  • [49] NEN Skeletal Metastasis Performance and the Correlation with Cell Proliferation: 112 Cases of 68Ga-DOTA-TATE Results Analysis
    Xie, Q.
    Lu, M.
    Li, J.
    Li, N.
    Yang, Z.
    Yu, J.
    NEUROENDOCRINOLOGY, 2020, 110 : 278 - 278
  • [50] Improved automated clinical production of 68Ga-DOTA-TATE for targeting somatostatic receptor-positive neuroendocrine tumors
    Arksey, Natasha
    Schneider, Bernadette
    Iagaru, Andrei
    Chin, Frederick T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
12345